Benzinga's Top Pre-Market Losers

Pain Therapeutics Inc. PTIE dipped 45.01% to $5.32 in the pre-market session after the company CEO revealed a letter from Pfizer PFE of reassessing its endorsement of the Remoxy program. Santarus, Inc. SNTS shares fell 6.09% to $20.20 in the pre-market trading after the company announced the launching of a Proposed Secondary Common Stock Offering by a Selling Stockholder, on Thursday. Newmont Mining Corporation NEM shares dropped 2.29% to $33.16 in pre-market trading. Newmont Mining Corporation's trailing twelve-months ROE is 5.95%. Eli Lilly and Company LLY dipped 1.04% to $54.56 in the pre-market session after the company announced its Enzastaurin Phase III Study had failed to meet Primary Endpoint in Diffuse Large B-Cell Lymphoma.